| # | Drug | Count |
|---|---|---|
| 0 | LOPINAVIR AND RITONAVIR | 17 |
| 1 | LAMIVUDINE AND ZIDOVUDINE | 16 |
| 2 | EFAVIRENZ | 11 |
| 3 | ABACAVIR SULFATE | 8 |
| 4 | NEVIRAPINE | 6 |
| 5 | ALLOPURINOL | 3 |
| 6 | RITONAVIR | 2 |
| 7 | CETIRIZINE HYDROCHLORIDE | 1 |
| 8 | FOLIC ACID | 1 |
| 9 | INSULIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 16 | 0.0021 |
| 1 | LOPINAVIR AND RITONAVIR | 17 | 0.0013 |
| 2 | EFAVIRENZ | 11 | 0.0010 |
| 3 | ABACAVIR SULFATE | 8 | 0.0008 |
| 4 | NEVIRAPINE | 6 | 0.0007 |
| 5 | METHYLDOPA | 1 | 0.0002 |
| 6 | ZIDOVUDINE | 1 | 0.0001 |
| 7 | RITONAVIR 100 MG | 1 | 0.0001 |
| 8 | LAMIVUDINE | 1 | 0.0000 |
| 9 | PAROXETINE HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 12 | 0.0005 |
| 1 | Protease Inhibitor [EPC] | 17 | 0.0004 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0003 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 17 | 0.0003 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 16 | 0.0001 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Vitamin D [EPC] | 1 | 0.0000 |
| 8 | Vitamin B12 [EPC] | 1 | 0.0000 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |